Header Logo

Search Results (28)

More Search Options
MatchTypeWhy
Safety of resuming anti-PD-1 in patients with immune-related adverse events (irAEs) during combined anti-CTLA-4 and anti-PD1 in metastatic melanoma.Academic Article Why?
Saygin, DidemPerson Why?
Pollack, MarkPerson Why?
Bennett, DavidPerson Why?
Barnes, LisaPerson Why?
Singh, AjaypalPerson Why?
Della Valle, CraigPerson Why?
Wilson, RobertPerson Why?
Singh, KernPerson Why?
Cole, BrianPerson Why?
Leurgans, SuePerson Why?
Forsythe, BrianPerson Why?
Verma, NikhilPerson Why?
Block, JoelPerson Why?
Buchman, AronPerson Why?
Per Page    Page  of 2last Nextnext
Prev
Search Criteria
  • Immune
  • related
  • adverse
  • events
Filter by Type
_
Click "Why?" to see why an item matched the search.